RESISTIN, VISFATIN, ADIPONECTIN, AND LEPTIN: RISK OF BREAST CANCER IN PRE-AND POSTMENOPAUSAL SAUDI FEMALES AND THEIR POSSIBLE DIAGNOSTIC AND PREDICTIVE IMPLICATIONS AS NOVEL BIOMARKERS

ASSIRI, A.. (2015). RESISTIN, VISFATIN, ADIPONECTIN, AND LEPTIN: RISK OF BREAST CANCER IN PRE-AND POSTMENOPAUSAL SAUDI FEMALES AND THEIR POSSIBLE DIAGNOSTIC AND PREDICTIVE IMPLICATIONS AS NOVEL BIOMARKERS. DISEASE MARKERS, -(-), 0-0. SID. https://sid.ir/paper/713380/en

ASSIRI A.. RESISTIN, VISFATIN, ADIPONECTIN, AND LEPTIN: RISK OF BREAST CANCER IN PRE-AND POSTMENOPAUSAL SAUDI FEMALES AND THEIR POSSIBLE DIAGNOSTIC AND PREDICTIVE IMPLICATIONS AS NOVEL BIOMARKERS. DISEASE MARKERS[Internet]. 2015;-(-):0-0. Available from: https://sid.ir/paper/713380/en

A. ASSIRI, “RESISTIN, VISFATIN, ADIPONECTIN, AND LEPTIN: RISK OF BREAST CANCER IN PRE-AND POSTMENOPAUSAL SAUDI FEMALES AND THEIR POSSIBLE DIAGNOSTIC AND PREDICTIVE IMPLICATIONS AS NOVEL BIOMARKERS,” DISEASE MARKERS, vol. -, no. -, pp. 0–0, 2015, [Online]. Available: https://sid.ir/paper/713380/en